2014
DOI: 10.1016/j.annepidem.2013.12.009
|View full text |Cite
|
Sign up to set email alerts
|

Peripheral neuropathy and Guillain-Barré syndrome risks associated with exposure to systemic fluoroquinolones: a pharmacovigilance analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
37
0
3

Year Published

2014
2014
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 55 publications
(40 citation statements)
references
References 14 publications
0
37
0
3
Order By: Relevance
“…22 The mechanism of action 23 involves the inhibition of bacterial DNA topoisomerase II (gyrase) and topoisomerase IV, which are enzymes involved in untwining bacterial DNA during the replication process. Regrettably, CIP has also been shown to decrease the viability of eukaryotic cells, leading to multiple adverse effects 24,25 , such as tendinopathies 26 and peripheral neuropathy 27,28 , due to a decline in the synthesis of proteins encoded in mitochondrial deoxyribonucleic acid (mtDNA). Analysis of mtDNA from CIP-treated cells revealed the presence of site-specific, double-stranded DNA breaks 29 , which were attributed to inhibition of mitochondrial topoisomerase II activity, functionally and structurally similar to that found in bacteria.…”
Section: Discussionmentioning
confidence: 99%
“…22 The mechanism of action 23 involves the inhibition of bacterial DNA topoisomerase II (gyrase) and topoisomerase IV, which are enzymes involved in untwining bacterial DNA during the replication process. Regrettably, CIP has also been shown to decrease the viability of eukaryotic cells, leading to multiple adverse effects 24,25 , such as tendinopathies 26 and peripheral neuropathy 27,28 , due to a decline in the synthesis of proteins encoded in mitochondrial deoxyribonucleic acid (mtDNA). Analysis of mtDNA from CIP-treated cells revealed the presence of site-specific, double-stranded DNA breaks 29 , which were attributed to inhibition of mitochondrial topoisomerase II activity, functionally and structurally similar to that found in bacteria.…”
Section: Discussionmentioning
confidence: 99%
“…There was a temporal association of the urinary tract infection, ciprofloxacin use, and the development of symptoms in patient 2. Both fluoroquinolone use and infection are known to be associated with IMN, and their possible causal role in the condition of patient 2, although unlikely, cannot be excluded [15,16]. …”
Section: Discussionmentioning
confidence: 99%
“…Todos los datos del estudio fueron obtenidos de forma automática a través de extracción electrónica de las historias clí-nicas (29 20). No obstante, la diferencia en término de medias no fue clínicamente significativa (25±8,6 días en el grupo de soluciones balanceadas vs 24,8±8,9 en el grupo de SSN 0,9 %).…”
Section: Solución Salina En Pacientes Críticamen-te Enfermos: ¿Estamounclassified